Comparison of the pathogenicity and neutrophil and monocyte response between SARS‐CoV ‐2 prototype and Omicron BA .1 in a lethal mouse model
Animal Models and Experimental Medicine · 2025
DOI: 10.1002/ame2.12419 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Animal Models and Experimental Medicine, 2025. Verfasst von Na Rong und 8 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, St…. Hauptthemen laut MEDLINE: SARS-CoV-2, Neutrophils, Monocytes, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China, National Key Research and Development Project of China.
Abstract (Originalsprache)
Background
SARS‐CoV‐2, first identified in late 2019, has given rise to numerous variants of concern (VOCs), posing a significant threat to human health. The emergence of Omicron BA.1.1 towards the end of 2021 led to a pandemic in early 2022. At present, the lethal mouse model for the study of SARS‐CoV‐2 needs supplementation, and the alterations in neutrophils and monocytes caused by different strains remain to be elucidated.
Methods
Human ACE2 transgenic mice were inoculated with the SARS‐CoV‐2 prototype and Omicron BA.1, respectively. The pathogenicity of the two strains was evaluated by observing clinical symptoms, viral load and pathology. Complete blood count, immunohistochemistry and flow cytometry were performed to detect the alterations of neutrophils and monocytes caused by the two strains.
Results
Our findings revealed that Omicron BA.1 exhibited significantly lower virulence compared to the SARS‐CoV‐2 prototype in the mouse model. Additionally, we observed a significant increase in the proportion of neutrophils late in infection with the SARS‐CoV‐2 prototype and Omicron BA.1. We found that the proportion of monocytes increased at first and then decreased. The trends in the changes in the proportions of neutrophils and monocytes induced by the two strains were similar.
Conclusion
Our study provides valuable insights into the utility of mouse models for simulating the severe disease of SARS‐CoV‐2 prototype infection and the milder manifestation associated with Omicron BA.1. SARS‐CoV‐2 prototype and Omicron BA.1 resulted in similar trends in the changes in neutrophils and monocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, State Key Laboratory of Respiratory Health and Multimorbidity, Institute…
- Wuhan Servicebio Technology Co., Ltd., Wuhan, China.
ORCID-Profile: Jiangning Liu
Förderung
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- National Key Research and Development Project of China
- CAMS Innovation Fund for Medical Sciences
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Rong, N., Wu, J., Zhao, B., Peng, W., Yang, H., Zhang, G., Ruan, D., Wei, X., & Liu, J. (2025). Comparison of the pathogenicity and neutrophil and monocyte response between SARS‐CoV ‐2 prototype and Omicron BA .1 in a lethal mouse model. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12419
Vancouver
Rong N, Wu J, Zhao B, Peng W, Yang H, Zhang G, et al. Comparison of the pathogenicity and neutrophil and monocyte response between SARS‐CoV ‐2 prototype and Omicron BA .1 in a lethal mouse model. Animal Models and Experimental Medicine. 2025. doi:10.1002/ame2.12419
BibTeX
@article{Rong2025,
author = {Rong, Na and Wu, Jing and Zhao, Binbin and Peng, Wanjun and Yang, Hekai and Zhang, Gengxin and Ruan, Dangting and Wei, Xiaohui and Liu, Jiangning},
title = {Comparison of the pathogenicity and neutrophil and monocyte response between SARS‐CoV ‐2 prototype and Omicron BA .1 in a lethal mouse model},
journal = {Animal Models and Experimental Medicine},
year = {2025},
doi = {10.1002/ame2.12419}
}
EUVIMED